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Abstract
Background: To develop a Consumer Quality Index (CQI) Cancer Care questionnaire for measuring experiences
with hospital care of patients with different types of cancer.
Methods: We derived quality aspects from focus group discussions, existing questionnaires and literature. We
developed an experience questionnaire and sent it to 1,498 Dutch cancer patients. Another questionnaire measuring
the importance of the quality aspects was sent to 600 cancer patients. Data were psychometrically analysed.
Results: The response to the experience questionnaire was 50 percent. Psychometric analysis revealed 12 reliable
scales. Patients rated rapid and adequate referral, rapid start of the treatment after diagnosis, enough information and
confidence in the healthcare professionals as most important themes. Hospitals received high scores for skills and
cooperation of healthcare professionals and a patient-centered approach by doctors; and low scores for psychosocial
guidance and information at completion of the treatment.
Conclusions: The CQI Cancer Care questionnaire is a valuable tool for the evaluation of the quality of cancer care from
the patient’s perspective. Large scale implementation is necessary to determine the discriminatory powers of the
questionnaire and may enable healthcare providers to improve the quality of cancer care. Preliminary results indicate
that hospitals could improve their psychosocial guidance and information provision.
Keywords: Consumer Quality Index (CQI), Focus groups, Healthcare evaluation, Healthcare quality, Patient experience,
Quality indicators
Background
Cancer patients have to cope with a great deal of distress.
A recent study among patients with inoperable lung
cancer showed that for 27 percent of these patients their
experiences with healthcare services were among their
most important concerns. Waiting times, problems with
information and communication and a lack of continuity
in healthcare professionals are among the healthcare
experiences that cause distress [1]. In 2001 the Institute
of Medicine (IOM) postulated the theory of patient-
centeredness as one of the ways in which the healthcare
system could reduce patients’ problems, instead of add to
their burden. The IOM states that care should be patient-
centered, that it is respectful of and responsive to indivi-
dual patient’s preferences, needs, and values and that
patient values should guide all clinical decisions [2].
Patient-centered care has been associated with improved
patient satisfaction, better treatment adherence, improved
recovery and health outcomes, reduced readmission rates
and better seeking of follow-up care [3-6]. Therefore,
patient-centeredness of care is now seen as an important
quality of care aspect worldwide. In order to achieve
patient centered care measuring patient experiences with
healthcare is vital. Comparative measures of patient prefe-
rences can be used by healthcare professionals to improve
care, by patients to select their caregiver, by insurers to
contract doctors and hospitals and by hospital managers
and policy makers to monitor the quality of care [2,7].
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It is important to note that healthcare professionals
and patients do not always agree on what is important
in patient care. In 2010, Wessels et al. reported that
expertise and attitude of healthcare providers as well as
accessibility of services were more important to cancer
patients than healthcare professionals expected. More-
over, the importance of organisational and environmen-
tal aspects was overrated by healthcare professionals [8].
Patient centeredness can only be measured by asking the
patients themselves. When measuring patient experi-
ences, elements of patient centeredness as identified in
the literature (respect for patient needs and preferences,
involvement of family and friends, sensitivity to non-
medical and spiritual dimensions of care, collaboration
and team management, education and shared know-
ledge, free flow and accessibility of information) must be
included [9].
For measuring patient experiences, valid and reliable
instruments that have been developed in close inter-
action with patients should be used. In the Netherlands,
patients’ experiences are measured using a standardized
method, the Consumer Quality Index (CQI) [10]. This
CQI consist of a large ‘family’ of questionnaires and
interview protocols that are complemented with detailed
instructions about how to use these instruments (e.g. how
to draw samples, how to collect data, how to analyse and
report findings etc.). The CQI has been implemented in
numerous areas of healthcare where it provides infor-
mation for care providers to improve their service, for
policy makers to aid in determining policy, for health care
insurers to use in their negotiations with healthcare orga-
nisations and for patients to help them make informed
choices between healthcare providers [11]. Although
literature is inconsistent, Fung et al. show in their review
that the availability of publically accessible performance
data stimulates quality improvement at the hospital level
[12-14]. The CQI methodology is based on the American
CAHPS (Consumer Assessment of Healthcare Providers
and Systems) [15] and the Dutch QUOTE (QUality of care
through the patient’s eyes) [16] instruments. It entails a
unique combination of questions on the frequency with
which quality criteria are met and the importance of
aspects according to patients.
Cancer patients are generally regarded to have differ-
ent needs than patients who have not been confronted
with a potentially lethal disease. A number of studies has
measured the satisfaction and needs of cancer patients
with their healthcare [17-19]. Patients rated technical
quality of medical care, interpersonal and communica-
tion skills of doctors and accessibility of care as impor-
tant aspects [17]. Skarstein reported in 2002 that the
most important predictors of cancer patient satisfaction
were performance of nurses and physicians, level of
information perceived, outcome of health status,
reception at the hospital and anxiety [18]. In 2003,
Tamburini reported information needs (regarding diag-
nosis, future conditions, dialogue with doctors, economic
insurance solutions related to the disease) and improved
‘hotel’ services (bathrooms, meals, cleanliness) as impor-
tant aspects [19]. In 2009, a questionnaire measuring
cancer patients’ preferences was developed, based on the
outcome of 10 focus group interviews. Patients rated ex-
pertise, safety, performance and attitude of physicians and
nurses as the most important issues in cancer care [20].
Although it is important to measure the needs of
patients, their satisfaction and preferences, as was done
in the above-mentioned studies, it is more informative
to combine this with measuring patients’ actual ex-
periences with healthcare [16]. Reports of experiences
rather than satisfaction can give more direct guidance
on how to improve the provided healthcare [21]. In the
Netherlands, a questionnaire on patient experiences has
been developed for breast cancer patients [10]. However,
until now a generic questionnaire capable of measuring
experiences of patients with all types of cancer was not
available. A generic questionnaire has advantages: it can
be used for patients with all tumour types and makes
developing many tumour-specific questionnaires super-
fluous. Moreover, a generic questionnaire can be set
out among large patient groups, thereby making it
easier to benchmark quality of cancer care on a hospital
level.
We assumed that from the patient’s perspective, the
majority of healthcare experiences are not tumour-
specific. Therefore, the aim of the current study was to
develop a generic questionnaire to measure both pre-
ferences and experiences of patients with all types of
cancer. The questionnaire should be suitable for regis-
tration and improvement of quality of cancer healthcare,
through, for instance, the implementation in the auditing
procedure of hospitals. For the development of the ques-
tionnaire we combined multiple sources and worked in
close collaboration with the Dutch Federation of Cancer
patient Organisations (NFK) in order to ensure robust
and relevant outcomes that can be implemented in the
cancer care system. We performed focus group inter-
views with cancer patients, looked at quality criteria
devised by the NFK and already existing questionnaires.
The developed questionnaire was tested in a group of
cancer patients.
In addition to our question, can we develop a ques-
tionnaire that measures the actual experiences of cancer
patients, our research questions were:
1. What are the most important aspects of quality of
care according to cancer patients?
2. What are the actual experiences with these quality
aspects?
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3. Are there any differences in experiences between
subgroups of cancer patients?
Methods
A group of experts was formed, consisting of healthcare
professionals, patient organisations, health insurers and
researchers. This group was consulted for decisions
regarding the creation and adaptation of the questionnaire.
Patients with all types of malignant tumours were
included, as long as they received treatment in a Dutch
hospital or specialized cancer treatment centre. We
chose the following inclusion criteria for both the focus
group discussions and the questionnaires. Participants
were at least 18 years old and the last treatment occurred
no longer than two years before the focus group discus-
sion or conduct of the survey. This study was performed
in agreement with the declaration of Helsinki. Approval
by a medical ethics committee was not required. All
participants in this study gave written informed consent
for the use of the data provided by them. Data from focus
group discussions and questionnaires were analyzed
anonymously.
Sampling
The chairmen of the cancer patient organisations affilia-
ted to the Netherlands Federation of Cancer patient
organisations (NFK) invited all their active members,
ever diagnosed with cancer, through letters or e-mails to
participate in the focus group discussions.
The claims data of a Dutch healthcare insurance
company with national coverage, were used to draw a
random selection of 1,489 patients, ever diagnosed with
cancer, who received cancer care in any hospital in the
Netherlands, or in a specialized cancer center in the last
two year for the experience questionnaire. Patients were
selected using diagnosis-related groups codes (DRG
codes). It concerned patients with the following types of
cancer: lung, breast, colorectal, prostate, haematological,
gynaecological and skin. Basal cell cancer patients were
excluded (on their DRG code), since these patients are
not always told they have cancer. Receiving a ques-
tionnaire concerning cancer would cause unnecessary
distress. Patients in all phases of their treatment were
included, receiving surgical treatment, chemotherapy,
radiotherapy, immune therapy or hormonal treatment,
with the exception of patients in a palliative phase, who
were excluded through their DRG code. A second
random sample of 600 patients using the same criteria
was drawn for the importance questionnaire.
Construction of the questionnaire
Three focus group discussions were held with seven,
nine and nine cancer patients in November and December
of 2009. Each focus group discussion was chaired by a
researcher from the Centre for Consumer Experience in
Healthcare (Centrum Klantervaring Zorg, CKZ) and
Netherlands Institute for Health Services Research
(NIVEL) and a policy officer from the NFK. Discussions
were audio-taped with permission of the participants.
Each participant was asked to write down three positive
and three negative experiences with the hospital care
surrounding their referral, diagnosis, treatment or after-
care. Subjects were then discussed in the group. Two
researchers independently analyzed transcripts from the
focus group discussions for the presence of quality aspects
using descriptive thematic analysis.
Relevant items mentioned more than once were
included in the questionnaire, along with additional
important items from the following sources. These
included a list of quality aspects for cancer care from
the patient’s perspective created by the NFK [22] and a
list of general quality criteria from the patient perspective
in healthcare constructed by the Netherlands patient
consumer federation (NPCF) [23]. We also included qua-
lity aspects from three questionnaires. The first was the
EORTC-IN-PATSAT32 questionnaire from the European
Organisation for Research and Treatment of Cancer
(EORTC). This questionnaire is used to assess in-patient
satisfaction with cancer care [24]. The second question-
naire was the CQI breast care [10] developed by the
NIVEL and CKZ to assess patients’ experiences with
breast care. The third was the CQI hospital care [25],
developed by the NIVEL and CKZ, that measures the
quality of hospital care.
We developed an ‘experience’ questionnaire that mea-
sures the experiences of patients and an ‘importance’
questionnaire to assess the importance patients attach to
each quality aspect. Both questionnaires contained a
number of questions regarding patient characteristics.
All other questions in the experience questionnaire had
one of the following response categories ‘never-some-
times-usually-always’, ‘no not at all-somewhat-largely-yes
completely’, ‘none-some-most-all’, or one through ten for
grades. Responses, with the exception of grades, were
converted into a scale of one to four, where the highest
score was the most positive answer. The importance
questionnaire included all experience questions from the
experience questionnaire, with the response categories
‘not important-somewhat important-quite important-
very important’. These responses were also converted
into a scale of one to four, four being very important.
Pre-testing
All patients who took part in the focus group discussions
received the experience questionnaire with instructions to
comment on the clarity of the questions. They were asked
to judge how long it took them to fill out the question-
naire, to give comments on unclear wording, to record if
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questions were clear and if all important aspects were
covered in the questionnaire. The questionnaire was filled
out by 20 cancer patients. Unclear or incorrect questions
were altered before data collection.
Data collection
We based our data collection on the Dillman method
[26]. In April 2010 (week 0) an invitation letter with a
link to the online ‘experience’ questionnaire was sent to
1,498 cancer patients. An invitation with a link to the
‘importance’ questionnaire was sent to 600 additional
patients. In week 1, a note was sent thanking respon-
dents and reminding non-responders to a link to the
questionnaire. In week 4 another reminder was sent to
the non-responders along with a paper version of the
questionnaire. Finally, in week 6, a note was sent,
thanking respondents and reminding non-responders to
the questionnaire through a link to the website.
Analyses
Data were analyzed following the CKZ manual on the
development of CQI questionnaires [27]. In short, the
data entry of ten percent of the paper questionnaires
was checked for errors. Up to one percent was allowed.
Subsequently, a histogram was made for all questions to
identify values that are outside the scope of the answer
categories. Double entries (on patient identification num-
ber), and non-responders (with and without statement of
a reason) were removed from the dataset. Questionnaires
that were not filled out by the patient the questionnaire
was sent to, were removed. Finally, questionnaires where
less than 50 percent of mandatory questions were ans-
wered (<41) were removed. All questions were considered
mandatory with the exception of questions following a
‘skip-question’, a question where the answer given may
redirect the respondent to a certain question, thereby
skipping questions that are irrelevant. Representativeness
of respondents was checked by comparing our data on
age, gender and tumour type with numbers from the
Dutch National cancer registration (NKR) [28].
Importance questionnaire
For the importance questions we calculated the percentage
of responses in the highest category (very important). We
regarded the top 10 questions to be the most important
questions in the questionnaire and the bottom 10 ques-
tions to be eligible for removal from the questionnaire.
Experience questionnaire
For the experience questionnaire we performed analyses
on item-level to identify extremely skewed items (as a
rule of thumb: more than 90 percent of responses in the
most positive or the most negative answer category) and
questions with a high non-response (as a rule of thumb:
more than 5 percent). Subsequently, we performed
inter-item analyses to identify questions with a large
overlap in response. If two questions had a Pearson’s
correlation coefficient exceeding 0.70 and overlap con-
cerning content, one of the questions was considered
potentially redundant.
Prior to carrying out factor analyses on the experience
questionnaire, we removed extremely skewed items and
redundant questions. All remaining 73 questions with a
1 to 4 answer-scale were included in the factor analysis.
We performed principal component analysis with
oblique rotation in order to ascertain the underlying
structure of the questionnaire while taking into account
a certain minimal amount of overlap between factors
due to the fact that people who respond positively to
certain questions may also respond positively to other
questions. Questions with a factor load of more than 0.3
for a certain scale were included in the scale where they
had the highest factor load.
We performed reliability analyses on the formed
scales. The reliability of each scale was measured with
Cronbach’s α. A scale with an α greater than 0.70 was
considered reliable, a scale with an α between 0.60 and
0.70 was considered to be moderately reliable and was
not removed from the questionnaire. However, a mode-
rately reliable scale needs to be re-evaluated in future
measurements. The correlation of a question to all ques-
tions in its scale (item-test correlation (ITC)) was required
to be greater than 0.40 for inclusion in the scale. We also
registered those questions for which removal of the
question from the scale would lead to an increase in the
reliability of the scale (Cronbach’s α).
Subsequently, we calculated average scale scores with
95% confidence intervals (95% CIs) for all the scales in
the experience questionnaire and compared the averages
for the five most frequently reported tumour types using
ANOVA.
We calculated improvement scores in order to identify
quality aspects where patients had negative experiences
while regarding the aspect as important. These improve-
ment scores combine data from the experience question-
naire and the importance questionnaire. Scores are
defined by the mean score of a question (importance
questionnaire) times the percentage of people with a
negative experience (experience questionnaire) times
100 [10,16].
We discussed all results with the group of experts. The
final decision for removal of questions from a scale and
from the questionnaire was based on the results from the
psychometric analyses and on arguments from the group
of experts with respect to the content of the questions.
For international use, the final questionnaire was
translated, reviewed by a panel of experts and back-
translated according to the WHO guidelines [29].
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Results
Focus groups
In total 33 people registered for a focus group discussion,
24 ultimately attended. The 24 participants were distri-
buted over the three focus group discussions, 33 percent
were male and 67 percent were female. Participants had a
mean age of 57 years (sd=8, range 25–86). Participants had
tumours in one or more of 11 different tissues or organs,
the top three most frequently reported included blood and
bone marrow, breast and digestive tract. Analysis of the
focus group discussions together with the quality aspects
derived from the quality lists of the NFK and the NPCF,
the CQI questionnaires on breast cancer care and hospital
care and the EORTC-IN-PATSAT32 questionnaire resulted
in 19 quality aspects. These included hospital related topics
Table 1 Background characteristics of the focus group
participants, the respondents to the importance
questionnaire and the respondents to the experience
questionnaire
Focus
group
Importance
questionnaire
Experience
questionaire
N % N % N %
Age (years):
18-24 0 0 3 0.9 2 0.2
25-34 1 4.2 1 0.3 9 1.2
35-44 1 4.2 13 4.1 32 4.4
45-54 9 37.5 38 11.8 89 12.3
55-64 9 37.5 81 25.2 204 28.1
65-74 3 12.5 113 35.2 227 31.3
75 or older 1 4.2 72 22.4 163 22.5
Gender:
male 8 33.3 167 52.0 333 46.1
female 16 66.7 154 48.0 389 53.9
Highest education:
none 0 0 7 2.3 11 1.6
Primary education (1) 0 0 26 8.5 59 8.4
Lower secondary
education (2)
1 4.2 63 20.7 158 22.4
Upper secondary
education (3)
1 4.2 64 21.0 167 23.7
Post-secondary non-tertiary
education (4)
3 12.5 37 12.1 85 12.1
Short cycle tertiary
education (5)
5 20.8 27 8.9 69 9.8
Bachelor (6) 7 29.2 59 19.3 111 15.8
Master/Doctoral
(7 or higher)
7 29.2 21 6.9 32 4.6
Experienced health:
excellent 2 11.1 18 5.7 46 6.4
very good 3 16.7 57 18.0 102 14.2
good 6 33.3 172 54.3 367 51.0
reasonable 7 38.9 54 17.0 169 23.47
poor 0 0 16 5.1 36 5.0
Tumour type
(more than 1 answer possible)
total
408
total
732
Digestive tract 6 17.1 58 14.2 205 28
Lower respiratory tract 3 8.6 61 15.0 67 9.2
Breast 9 25.7 45 11.0 171 23.3
Male reproductive organs 1 2.9 79 19.4 153 20.9
Skin 1 2.9 43 10.5 70 9.6
Blood, bone marrow
and lymph nodes
7 20.0 29 7.1 45 6.1
Urinary tract 2 5.7 13 3.2 9 1.2
Female reproductive organs 3 8.6 16 3.9 73 10.0
Head and neck 1 2.9 16 3.9 4 0.5
Central nervous system 0 0 2 0.3
Bone or soft tissue 4 1.0 12 1.6
Table 1 Background characteristics of the focus group
participants, the respondents to the importance
questionnaire and the respondents to the experience
questionnaire (Continued)
Endocrine glands 1 2.9 3 0.7 4 0.5
Eye and orbit 1 2.9 2 0.5 3 0.4
Treatment received (more than 1 answer possible)
surgery 21 45.7 230 44.6 492 46.9
chemotherapy 11 23.9 115 22.3 141 13.4
radiotherapy 12 26.1 125 24.2 257 24.5
hormone treatment 2 4.3 44 8.5 127 12.1
immune therapy 2 0.4 32 3.1
Treating specialist
surgeon 13 19.7
medical specialist/oncologist 13 19.7
radiologist/radiotherapist 8 12.1
oncology nurse 5 7.6
nurse practitioner 3 4.5
psychologist/social worker 6 9.1
general practitioner 12 18.2
physical therapist 2 3.0
dietitian 3 4.5
dermatologist 1 1.5
Stage of treatment
tests to acertain diagnosis 4 1.3 13 1.9
diagnosis known, treatment
starts
4 1.3 8 1.2
during treatment 68 22.2 158 22.9
no further treatment possible 7 2.3 14 2.0
non-curative treatment 31 10.1 69 10.0
checks after treatment 168 54.9 374 54.1
treatment and checks after
treatment are finished
15 4.9 42 6.1
I don’t know (anymore) 9 2.9 13 1.9
Educational levels were described using the International Standard
Classification of Education (ISCED) categories (one through seven).
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(patient-centered approach, waiting times, information,
communication, skills of health professionals, psychosocial
care, cooperation between professionals, provisions in and
accessibility of the hospital, after care) and personal topics
(autonomy, safety, heritability, pain, fatigue, concentration
difficulties, sexuality, nutrition and medication); full list
available on request.
Pre-testing and experience questionnaire
The experience questionnaire used for pre-testing
contained 110 questions. There were 8 questions to
determine the type of cancer and hospital care received
and 14 questions on demographic characteristics of the
participants (termed ‘About yourself ’). Six questions, so
called skip-questions, were designed to direct parti-
cipants through the questionnaire. Some of these skip-
questions also measured patient experiences and were
therefore included in the analyses. The remaining 82
questions measured patient experiences.
The questions in the experience questionnaire were
grouped into the following themes: organisation of the
hospital, patient-centered approach by nurses, patient-
centered approach by doctors, information and commu-
nication, personal input, skills and knowledge of the
health professionals, cooperation and communication
between healthcare professionals, guidance and support,
end of the treatment, after care and grading of the
hospital. For pre-testing the questionnaire was filled out
by twenty cancer patients. Their input was used to
adjust the questionnaire, wording was clarified and
answer categories were adjusted. No questions were
removed. The adjusted version of the questionnaire was
subsequently used.
Importance questionnaire
The ‘importance’ questionnaire contained the same
questions as the ‘experience’ questionnaire on type of
cancer, hospital care and demographics. The remaining
80 questions corresponded to 80 of the 83 experience
questions in the pilot questionnaire. Three questions
regarding grading of hospital and healthcare professionals
were not included in the ‘importance’ questionnaire.
Response
Table 1 reports background characteristics of the res-
pondents. Tumour type indicates the tumour type re-
ported by the patient, not the tumour type from the
sample drawn. Several tumour types were reported in
addition to the ones from the inclusion criteria since the
questionnaire is designed for use in all tumour types.
Respondents could indicate more than one tumour type.
The experience questionnaire was sent to 1,498 patients.
This sample was representative for the Dutch cancer
patient population concerning age and gender. The people
in the sample for the experience questionnaire were only
slightly older, 6 percent was below 45 years, compared to
9 percent in the cancer patient population; 34 percent was
above 75 years, compared to 30 percent in the cancer
patient population. In the sample 49 percent were male,
compared to 52 percent in the cancer patient population.
The questionnaire was completed by 732 participants
(50 percent), 46 percent was male, 54 percent was female.
The mean age of participants was 65.8 years (se 0.45
years), see Table 1. Participants reported a malignancy in
one or more of 14 different tissues or organs (see Table 1),
the three most common were: digestive tract (28 percent),
breast (23 percent) and male reproductive organs
(21 percent).
The sample for the importance questionnaire also
contained 6 percent under 45 years and 34 percent
above 75 years, slightly older than the population of
cancer patients (Table 2). Furthermore, 48 percent was
male, compared to 52 percent in the cancer patient
population. The importance questionnaire was filled out
by 408 participants (68 percent). The age distribution in
this group was comparable to that of the experience
questionnaire (mean 67.1 years, se 0.56 years), 52 percent
was male and 48 percent was female. The three most
common tumours in this group were cancer in the male
reproductive organs (19 percent), lung cancer (15 percent)
and cancer in the digestive tract (14 percent) (Table 1).
Table 2 Background characteristics of the Dutch cancer
patient population [28]
Dutch cancer patient
population (2007)
Age (years) %
<45 9
45-60 21
60-75 40
>75 30
Gender
male 52
Tumour type
Digestive tract 19
Lower respiratory tract 13
Breast 20
Male reproductive organs 16
Skin 14
Blood, bone marrow and lymph nodes 10
Urinary tract 8
Female reproductive organs 6
head and neck 4.2
central nervous system 1
bone or soft tissue 2.6
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Important aspects
The ten most and least important aspects, based on the
results from the importance questionnaire, can be found
in Table 3. No significant differences were observed in
importance for the five most common tumour types
using ANOVA analyses (data not shown). Patients rated
rapid and adequate referral, consultation of other
doctors by the doctor if additional expertise is required,
rapid start of the treatment after diagnosis, enough
information and confidence in the health professionals
as the most important themes in the questionnaire.
Psychometric analyses
The psychometric analyses were performed on all
questions from the experience questionnaire measuring
patient experiences. There were no questions extremely
skewed, or with more than 5 percent non-response. We
identified five pairs of questions with a high mutual
correlation and overlapping content. Of the 83 experi-
ence questions, 55 fit into 11 reliable scales and one
moderately reliable scale. Each scale contained between
three and six questions. The scales contained questions
regarding the different time frames: treatment, after care
and referral to other healthcare professionals. Within
these time frames, there were scales regarding personal
attention, freedom of choice, guidance by and skills of
healthcare professionals, communication and the patient
centered approach of both doctors and nurses. The
scales and corresponding example questions can be
found in Table 4. The table contains the twelve scales
identified in the questionnaire before and after adjust-
ment of the scales based on the psychometric analyses.
Before adjustment eleven scales were reliable, one was
moderately reliable. After adjustment all twelve scales
were reliable.
Adjustment of the questionnaire
Eleven questions were eligible for removal from the
questionnaire because they reduced the reliability of a
scale, were not considered important by respondents,
had high inter-item correlation, or a combination. The
group of experts made the final decision for removal of
Table 3 The ten most and least important quality aspects according to cancer patients (importance questionnaire)
Rank Do you find it important that: % very
important*
Average importance
score # (95% CI)
Most important questions
1 your family doctor refers you to hospital as quickly as you would like 75 3.72 (3.67-3.78)
2 your treatment is started as soon after the diagnosis as you would like 74 3.72 (3.67-3.78)
3 there are regular checks to find new tumours, if your type of cancer is heritable 68 3.63 (3.56-3.70)
4 your doctor consults other doctors or refers you if additional expertise is required 68 3.65 (3.59-3.71)
5 the time between first examination and results was short 66 3.62 (3.55-3.68)
6 the time between referral by the family doctor and the first examination was less than 6 days 65 3.59 (3.52-3.66)
7 you have confidence in the doctors and nurses in the hospital 65 3.63 (3.57-3.68)
8 doctors and nurses in the hospital give you the best possible care 61 3.60 (3.54-3.66)
9 you regularly receive information about the effect of the treatment, during the treatment period 57 3.54 (3.48-3.60)
10 you receive sufficient information about the (dis-) advantages of different treatments, so you can
make a proper choice
56 3.50 (3.43-3.57)
Least important questions
1 careproviders inform you about patient organisations 10 2.53 (2.44-2.63)
2 you can talk to doctors and/or nurses about alternative treatments and medicines, if you wish 15 2.66 (2.56-2.76)
3 you are informed if the waiting time is longer than expected 17 2.80 (2.71-2.89)
4 nurses are polite to you 18 2.98 (2.91-3.06)
5 nurses show personal interest in you 18 2.89 (2.80-2.97)
6 you are offered help with questions regarding resuming you regular activities, during aftercare 19 2.76 (2.65-2.86)
7 you receive information from the hospital about possibilities for psychosocial guidance, during
aftercare
19 2.86 (2.77-2.95)
8 it is regularly checked if you need help dealing with the emotions brought about by the disease
and treatment
19 2.81 (2.72-2.91)
9 you are called at home by a care provider from the hospital within a week after completion of
the treatment, to discuss how you are doing
19 2.81 (2.71-2.90)
10 the waiting time for outpatient appointments in the hospital is less than 15 minutes 20 2.78 (2.68-2.87)
Questions were translated from Dutch for this article. * The percentage of people who scored the item as being very important. # Importance scores range from 1
(not important) to 4 (very important).
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10 items from the questionnaire and merger of 2
questions into one. This resulted in a questionnaire
containing 99 questions, see additional file 1. Six of the
removed questions were part of a scale, for three of
these, removal increased the alpha value of the scale, for
the other three removal decreased the α. The adjusted
scales all had an α value greater than 0.70 and were
therefore reliable, see Table 4. The English translated
version of the adjusted questionnaire can be found in
Additional file 1.
Scale scores
Average scale scores based on the experience question-
naire can be found in Figure 1. On average hospitals had
low scores for ‘Psychosocial guidance’, ‘Other investiga-
tions and treatments’ and ‘Information at completion of
treatment’. Highest scores were found for ‘Skills and
cooperation of healthcare professionals’ and for ‘Patient-
centered approach by doctors’. Doctors scored signifi-
cantly higher than nurses with regard to patient-centered
approach (p<0.001). The average scale scores differed
significantly (p<0.05) depending on the tumour type for
five scales (Freedom of choice, Psychosocial guidance,
Continuity of care by healthcare professional/side effects
and complaints, Patient-centered approach by nurses and
Information at completion of treatment) (see Figure 2).
Highest scores were invariably given by breast cancer
patients. The lowest scores were given by patients with
gastro-intestinal cancer, skin cancer and/or cancer of the
female reproductive organs, depending on the scale.
Improvement scores
We used the experience and importance questionnaires
to determine improvement scores in order to identify
aspects where patients had a high percentage of bad
experiences combined with a high average importance
score. Our analyses showed that the aspect with the
highest improvement score was ‘if your cancer is heri-
table, was examination of your relatives discussed?’. Up
to 70 percent of patients, for whom this was relevant
(i.e. they did not indicate the question was not appli-
cable), reported a negative experience with this aspect.
The ten most important aspects included two questions
regarding heritable cancer, four questions regarding
aftercare and two questions regarding planning of ap-
pointments (see Table 5).
The lowest improvement scores regarded attitude and
information provision by healthcare professionals. The
Table 4 Reliability of the scales in the experience questionnaire, before and after removal of redundant questions
based on psychometric analyses
Scale Example of question Before adjustment After adjustment
no. questions α no. questions α
1 Personal attention during aftercare During aftercare, was attention paid
to complaints of fatigue?
6 0.80 5 0.77
2 Cooperation and communication
between healthcare professionals
Was the advice given by different
healthcare professionals congruent?
4 0.78 3 0.81
3 Freedom of choice Were you given enough time
to choose a treatment?
3 0.79
4 Skills and cooperation of healthcare
professionals
Did doctors and nurses in the hospital give
you the best possible care?
6 0.76
5 Psychosocial guidance Did the hospital provide you with information
about guidance for dealing with emotions and
practical issues caused by cancer?
5 0.83 4 0.86
6 Other investigations and treatments Was it possible to discuss a second opinion
with your doctor?
4 0.76
7 Information during treatment Did the healthcare professionals give you
enough information?
6 0.79
8 Continuity of care by healthcare
professional/side effects and complaints
Were doctors and nurses prepared to talk
to you about things you thought had
gone wrong?
4 0.71
9 Patient-centered approach by doctors Did the doctors listen carefully to you? 5 0.87 4 0.86
10 Patient-centered approach by nurses Did the nurses take you seriously? 5 0.86 4 0.85
11 Information at completion of treatment At completion of the treatment, did you
receive information about the possibility
of psychosocial care?
4 0.68 3 0.73
12 Transfer to other healthcare professionals Were important persons and institutions
(general practitioner, rehabilitation)
informed of the completion of your treatment?
3 0.75
no. questions: the number of questions each scale contains. α: Cronbach’s alpha,. Scales for which the fields ‘after adjustment’ are blank, were not altered.
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low scores were caused mainly by the low percentage of
negative experiences (1.93-3.46 percent) reported (see
Table 5).
Discussion
We developed a questionnaire that measures patient
experiences with cancer care in hospitals for patients
with all types of cancer. The revised version of the
questionnaire contains 99 questions and 12 reliable
scales (the original questionnaire prior to psychometric
analyses contained 110 questions). It measures a broad
array of topics specific to the needs and wishes of cancer
patients, including provision of information at different
stages of the treatment, continuity of care, psychosocial
guidance and personal attention after completion of the
treatment. For the majority of scales and for the items
rated most important by patients we found no differ-
ences between tumour types, although certain tumour-
specific results were found. This illustrates the advantage
of a generic questionnaire. It can be used for patients
with all tumour types (compared to having to develop
many tumour-specific questionnaires). Moreover, a gen-
eric questionnaire can be sent out to many patients per
hospital, thereby making it possible to make large scale
comparisons between hospitals.
With regard to our first research question - What are
the most important aspects of quality of cancer care
according to patients? - we found that the most import-
ant themes were: rapid and adequate referral, consul-
tation of other professionals by the doctor, rapid start of
the treatment after diagnosis, the need for information
and confidence in the healthcare professional (Table 3).
The first three were previously identified in breast
cancer patients [20,30]. The latter two partially confirm
previous findings (provision of information, communica-
tion skills, accessibility of care and technical quality of
the medical care) [17-20]. Important items from the
theory of patient-centeredness can also be identified in
these themes (collaboration and team management,
education and shared knowledge, free flow and accessi-
bility of information), supporting the construct validity
of these subscales.
The answer to our second research question - What
are the actual experiences of cancer patients with these
quality aspects? can be derived from the scores on the
different scales in the experience questionnaire (Figure 1).
Highest scores were given for skills and cooperation of
healthcare professionals and for patient-centered approach
by doctors. Interestingly, hospitals scored relatively low on
psychosocial guidance, on possibilities for other investiga-
tions and treatments and on information after completion
of the treatment. In addition, our improvement scores
showed that examination of relatives of patients with a
heritable type of cancer was not frequently discussed with
Figure 1 Average scale score and 95% confidence intervals for the twelve scales of the experience questionnaire. Scores ranged from 1
to 4, 4 being the best possible score.
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patients even though patients found this to be important.
A study published in 2009 by Damman et al. among breast
cancer patients reported high improvement scores for
referral to rehabilitation, the possibility of making an
appointment rapidly and referral to psychosocial care [10].
This is generally in agreement with our findings.
Our third research question was ‘Are there any dif-
ferences in experiences between subgroups of cancer
patients?’ Based on the experience questionnaire, we
observed statistically significant differences between pa-
tients with different tumour types for five scales (Freedom
of choice, Psychosocial guidance, Continuity of care by
healthcare professional/side effects and complaints,
Patient-centered approach by nurses and Information at
completion of treatment). Breast cancer patients reported
most positive experiences for all these scales (Figure 2).
This can be explained by the improvement in the quality
and speed of breast cancer detection and treatment in the
Netherlands in the recent years [31]. In contrast to most
studies, our questionnaire allows participants to rate
doctors and nurses separately. This resulted in signi-
ficantly higher scores for doctors compared to nurses
regarding their attitude towards patients. This is a surpri-
sing result because in other studies the contrary has been
found [32,33]. Moreover, from the focus groups we had
the impression that nurses are found to be more patient-
centred than physicians. It must be noted that the low
number of respondents with cancer of the urinary tract,
head and neck, and central nervous system, prevent us
from drawing conclusions regarding the use of the ques-
tionnaire in specific groups of patients.
A major strength of this study is that we incorporated
the importance cancer patients attach to different quality
aspects in several phases of the construction of the ques-
tionnaire. Our focus group discussions with cancer pa-
tients ensured that quality aspects important to patients
were included in the pilot version of the questionnaire.
Sending out the importance questionnaire enabled us to
exclude questions that are considered unimportant by
patients and to retain questions that would be eliminated
Figure 2 Average scale score and 95% confidence intervals for scales with statistically significant differences in average score between
tumour types (ANOVA p<0.05). Differences in average scale scores are reported for the five most commonly reported tumour types.
Calculations are based on 205 tumours of the digestive tract, 171 breast tumours, 153 tumours of the male reproductive organs, 73 tumours of
the female reproductive organs and 70 tumours of the skin.
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from the questionnaire based on their psychometric
properties but were deemed important by patients. Our
questionnaire includes a broad range of themes, derived
from multiple sources and is therefore very comprehen-
sive. An additional advantage is that the questionnaire is
generic for cancer patients. This allows for the compari-
son of different tumour types. Moreover, our results allow
policy makers, healthcare professionals and patient orga-
nisations to learn from the type of care given to breast
cancer patients, as we show high scores are given by
breast cancer patients.
A possible drawback of the comprehensive nature of
the questionnaire is that it may be considered long by
patients, although only 13 (out of 732) participants
reported this complaint. The experience questionnaire
showed a response of 50 percent. This is comparable to
what is found in the literature (42–75 percent) [34-38].
The literature is not in agreement as to whether the
number of questions in a questionnaire influences the
response rate. Sitzia et al. found in 1998 in a review
among 210 studies that there was no effect, while
Edwards et al. found in a review in 2002 that shorter
questionnaires have higher response rates [36,39,40]. It
appears as though the number of questions in the
questionnaire, although rather high, did not form a
substantial barrier for patients in the current study.
There was a difference in response between the experi-
ence questionnaire (50 percent) and the importance
questionnaire (68 percent). It is unclear how this dif-
ference arose, since the distribution of age and gender
for respondents and non-respondents in both groups
was highly similar, the number of questions was com-
parable in both questionnaires and invitations to partici-
pate in the study were sent in the same way for both
questionnaires. The only substantial difference found
between the two groups was in the types of tumours
reported by the patients. This may have caused a diffe-
rent response. Compared to the Dutch cancer popula-
tion, there were fewer patients with lower respiratory
tract cancer and more with cancer of the female
Table 5 Improvement scores for, ten questions with the highest improvement score and ten questions with the lowest
improvement score
Question Average
importance score
% negative
experiences
Improvement
score
Ten highest improvement scores
If your cancer is heritable, was examination of your relatives discussed? 3.35 69.34 2.33
After completion of the treatment, were you called at home within a week by a healthcare
professional to discuss how you were doing?
2.81 71.71 2.01
Did you receive information regarding participation in medical research? 2.76 72.10 1.99
After completion of the treatment, did you receive information regarding the possibilities of
care for your emotions?
2.86 66.18 1.89
Were you informed if the waiting time was longer than expected 2.80 63.30 1.77
Were multiple appointments in this hospital planned for the same day? 3.25 53.21 1.73
During aftercare, were you offered help with problems surrounding your feelings? 2.86 57.32 1.64
Did healthcare professionals inform you about patient organisations? 2.53 63.35 1.61
During aftercare, were you offered help with questions regarding getting back into your
normal daily routine?
2.76 57.75 1.59
If your cancer is heritable, are you regularly checked for any new tumours? 3.63 41.90 1.52
Ten lowest improvement scores
Were the doctors polite to you? 3.08 1.93 0.06
Were the nurses polite to you? 2.98 2.21 0.07
Were doctors and nurses aware of your situation? 3.60 2.06 0.07
Did the doctors and nurses treat you in a skilful manner? 3.44 2.6 0.09
Was written information clear? 3.20 2.87 0.09
Did healthcare professionals give you contradictory information? 3.50 2.63 0.09
Did the information you received beforehand correspond well with what happened during
investigation and treatment?
3.33 3.54 0.12
Did the doctors take you seriously? 3.49 3.45 0.12
Did the doctor give you the test results personally? 3.40 3.57 0.12
Did you trust the doctors and nurses? 3.63 3.46 0.13
For each question the average importance score is shown as measured in the importance questionnaire (1 is lowest, 4 is highest), the percentage of negative
experiences (the two most negative categories were taken together, for instance ‘none’ and ‘some’ or ‘never’ and sometimes’).
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reproductive organs among respondents to the experience
questionnaire. It remains unclear why this difference exists
since respondents from the different diagnosis groups
were all selected and approached in exactly the same way.
The respondents to the importance questionnaire had the
same five most frequently reported tumour types as the
Dutch cancer population, making systematic sampling
errors unlikely.
The fact that the questionnaire is in Dutch also intro-
duces a possible bias. Dutch residents who do not speak
the Dutch language are less likely to fill out the ques-
tionnaire, even though we allowed people to fill out the
questionnaire with the aid of an interpreter. This was
reflected in our results, 94 percent of the respondents
were of Dutch descent. This is observed as well in other
questionnaire-based studies, 70–79 percent of a study
population in New Zealand and the USA was Caucasian
[41,42]. The translated version of the questionnaire
(additional file 1) will enable international comparisons.
In order to keep the questionnaire down to a reason-
able size we did not include certain aspects of cancer
care that only apply to specific subgroups. This may be
considered a limitation. However, CQI questionnaires
for specific subgroups have been or are being developed
for breast cancer care [10] and for radiotherapy [43].
The combination of these questionnaires will result in
both complete and specific information on the experi-
ences of the cancer population.
Although the sample for this study was drawn by a
Dutch health insurance company with national coverage,
no data are available on the hospitals where the res-
pondents were treated. Therefore we cannot guarantee
national coverage of our data. In future research stratifica-
tion on hospital level should be applied so that national
coverage of the respondent population can be ensured and
results can be generalized to the whole country.
Based on the research described here, the current
questionnaire should be tested for its ability to discri-
minate between hospitals, so it can be used for compari-
son of hospitals. Preferably this is to be done in a group
of cancer patients with one specific tumour type, to rule
out any potential differences caused by the tumour type.
Furthermore, using the English translated version of the
questionnaire will facilitate international use of the ques-
tionnaire and comparison with international cancer care.
Conclusion
We developed a questionnaire that measures the import-
ance of aspects and the experiences of all types of cancer
patients based on quality aspects formulated by patients.
We showed known and new quality aspects that are very
important to patients, the experiences of patients with
respect to these aspects, and that differences exist in
experiences between people with different tumour types.
After testing for discriminatory power our questionnaire
can be used nation-wide to measure quality of cancer care
from the patient perspective and to identify differences in
the experiences of patients in different hospitals. Finally,
in contrast to most previously developed questionnaires,
our questionnaire makes a distinction between care pro-
vided by doctors and by nurses.
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